Diantha Duvall Genocea Biosciences, Inc. (GNCA) insider trading activity

GNCA Quotes by TradingView

Diantha Duvall is CHIEF FINANCIAL OFFICER of GENOCEA BIOSCIENCES, INC.. Currently has a direct ownership of 75,388 shares of GNCA, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2022, when has been sold 1,355 shares (Common Stock) at a price of $0.06 per share, resulting in proceeds of $81. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.4K
0% 3M change
0% 12M change
Total Value Held $0

Diantha Duvall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2022
SELL
Open market or private sale
$81 $0.06 p/Share
1,355 Reduced 1.77%
75,388 Common Stock
May 26 2022
SELL
Open market or private sale
$1,953 $0.08 p/Share
24,407 Reduced 24.13%
76,743 Common Stock
Apr 04 2022
SELL
Open market or private sale
$1,204 $1.25 p/Share
963 Reduced 1.04%
91,775 Common Stock
Mar 16 2022
SELL
Open market or private sale
$3,160 $1.1 p/Share
2,873 Reduced 3.0%
92,738 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
-
37,500 Added 28.17%
95,611 Common Stock
Mar 15 2021
BUY
Grant, award, or other acquisition
-
37,500 Added 50.0%
37,500 Common Stock

Also insider at

CRIS
CURIS INC Healthcare
CFO
DD

Diantha Duvall

CHIEF FINANCIAL OFFICER
Cambridge, MA

Track Institutional and Insider Activities on GNCA

Follow GENOCEA BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GNCA shares.

Notify only if

Insider Trading

Get notified when an Genocea Biosciences, Inc. insider buys or sells GNCA shares.

Notify only if

News

Receive news related to GENOCEA BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GNCA